Jozarni J Dlabac-de Lange1, Edith J Liemburg2, Leonie Bais3, Aida T van de Poel-Mustafayeva4, Elly S M de Lange-de Klerk5, Henderikus Knegtering6, André Aleman7. 1. University of Groningen, University Medical Center Groningen, Department of Psychiatry, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Rob Giel Research Centrum, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Neuroscience and BCN Neuroimaging Center, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands. Electronic address: j.j.l.a.s.n.dlabac@umcg.nl. 2. University of Groningen, University Medical Center Groningen, Rob Giel Research Centrum, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Neuroscience and BCN Neuroimaging Center, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands; Lentis Psychiatric Institute, Lentis Research, Hereweg 80, 9725 AG Groningen, The Netherlands. 3. University of Groningen, University Medical Center Groningen, Department of Neuroscience and BCN Neuroimaging Center, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands; Lentis Psychiatric Institute, Lentis Research, Hereweg 80, 9725 AG Groningen, The Netherlands. 4. University of Groningen, University Medical Center Groningen, Department of Psychiatry, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. 5. VU University Medical Centre, Department of Epidemiology and Biostatistics, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. 6. University of Groningen, University Medical Center Groningen, Department of Psychiatry, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Rob Giel Research Centrum, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Neuroscience and BCN Neuroimaging Center, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands; Lentis Psychiatric Institute, Lentis Research, Hereweg 80, 9725 AG Groningen, The Netherlands. 7. University of Groningen, University Medical Center Groningen, Department of Neuroscience and BCN Neuroimaging Center, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands.
Abstract
BACKGROUND:Prefrontal repetitive Transcranial Magnetic Stimulation (rTMS) may improve negative symptoms in patients with schizophrenia, but few studies have investigated the underlying neural mechanism. OBJECTIVE: This study aims to investigate changes in the levels of glutamate and glutamine (Glx, neurotransmitter and precursor) and N-Acetyl Aspartate (NAA) in the left dorsolateral prefrontal cortex of patients with schizophrenia treated with active bilateral prefrontal rTMS as compared to sham-rTMS, as measured with 1H-Magnetic Resonance Spectroscopy (1H-MRS). METHODS: Patients were randomized to a 3-week course of active or sham high-frequency rTMS. Pre-treatment and post-treatment 1H-MRS data were available for 24 patients with schizophrenia with moderate to severe negative symptoms (Positive and Negative Syndrome Scale (PANSS) negative subscale ≥ 15). Absolute metabolite concentrations were calculated using LCModel with the water peak as reference. To explore the association between treatment condition and changes in concentration of Glx and NAA, we applied a linear regression model. RESULTS: We observed an increase of Glx concentration in the active treatment group and a decrease of Glx concentration in the group receiving sham treatment. The association between changes in Glx concentration and treatment condition was significant. No significant associations between changes in NAA and treatment condition were found. CONCLUSIONS: Noninvasive neurostimulation with high-frequency bilateral prefrontal rTMS may influence Glx concentration in the prefrontal cortex of patients with schizophrenia. Larger studies are needed to confirm these findings and further elucidate the underlying neural working mechanism of rTMS.
RCT Entities:
BACKGROUND: Prefrontal repetitive Transcranial Magnetic Stimulation (rTMS) may improve negative symptoms in patients with schizophrenia, but few studies have investigated the underlying neural mechanism. OBJECTIVE: This study aims to investigate changes in the levels of glutamate and glutamine (Glx, neurotransmitter and precursor) and N-Acetyl Aspartate (NAA) in the left dorsolateral prefrontal cortex of patients with schizophrenia treated with active bilateral prefrontal rTMS as compared to sham-rTMS, as measured with 1H-Magnetic Resonance Spectroscopy (1H-MRS). METHODS:Patients were randomized to a 3-week course of active or sham high-frequency rTMS. Pre-treatment and post-treatment 1H-MRS data were available for 24 patients with schizophrenia with moderate to severe negative symptoms (Positive and Negative Syndrome Scale (PANSS) negative subscale ≥ 15). Absolute metabolite concentrations were calculated using LCModel with the water peak as reference. To explore the association between treatment condition and changes in concentration of Glx and NAA, we applied a linear regression model. RESULTS: We observed an increase of Glx concentration in the active treatment group and a decrease of Glx concentration in the group receiving sham treatment. The association between changes in Glx concentration and treatment condition was significant. No significant associations between changes in NAA and treatment condition were found. CONCLUSIONS: Noninvasive neurostimulation with high-frequency bilateral prefrontal rTMS may influence Glx concentration in the prefrontal cortex of patients with schizophrenia. Larger studies are needed to confirm these findings and further elucidate the underlying neural working mechanism of rTMS.
Authors: Iska Moxon-Emre; Paul E Croarkin; Zafiris J Daskalakis; Daniel M Blumberger; Rachael E Lyon; Hideaki Tani; Peter Truong; Meng-Chuan Lai; Pushpal Desarkar; Napapon Sailasuta; Peter Szatmari; Stephanie H Ameis Journal: Brain Sci Date: 2022-06-15
Authors: Nathaniel R Bridges; Richard A McKinley; Danielle Boeke; Matthew S Sherwood; Jason G Parker; Lindsey K McIntire; Justin M Nelson; Catherine Fletchall; Natasha Alexander; Amanda McConnell; Chuck Goodyear; Jeremy T Nelson Journal: Front Hum Neurosci Date: 2018-03-26 Impact factor: 3.169
Authors: Heidi Gröhn; Bernadette T Gillick; Ivan Tkáč; Petr Bednařík; Daniele Mascali; Dinesh K Deelchand; Shalom Michaeli; Gregg D Meekins; Michael J Leffler-McCabe; Colum D MacKinnon; Lynn E Eberly; Silvia Mangia Journal: Front Neurosci Date: 2019-11-27 Impact factor: 4.677